Peer-reviewed. NIH-funded. Harvard validated. Lancet published.

Research from Beth Israel Deaconess Medical Center, UC San Diego School of Medicine, and Harvard Medical School demonstrates that speech-based deep neural networks can model Huntington's disease progression before clinical symptoms appear.

Peer-reviewed research demonstrates that acoustic and linguistic features in the voice can detect manifest Huntington's disease with clinical accuracy.

Clinical research validates acoustic and linguistic voice analysis as a reliable indicator of Huntington's disease progression.

Research conducted with Beth Israel Deaconess Medical Center and UMass Chan Medical School achieves AUC 0.97 for Parkinson's detection from conversational speech — using natural, unconstrained speech without specialized equipment.

Research published in The Lancet Regional Health, conducted with Japan's National Cerebral and Cardiovascular Center, confirms that voice biomarkers accurately detect Mild Cognitive Impairment.

Peer-reviewed research demonstrates that spontaneous conversational speech contains detectable biomarkers for Mild Cognitive Impairment — enabling screening without scripted prompts or clinical interviews.

Clinical research establishes voice analysis as a validated approach to early MCI detection — addressing a condition missed by primary care physicians in 92% of cases.

A real-world health innovation study demonstrates that voice biomarker technology provides objective data for assessing cognitive wellness — improving patient outcomes in community health settings.

With an estimated 46.7 million Americans aged 65 and older living with Alzheimer's or related dementia, peer-reviewed research validates vocal biomarker models for early Alzheimer's detection — identifying cases before clinical symptoms become apparent.

Research demonstrates that Alzheimer's disease indicators are detectable through vocal biomarker analysis in conversational settings — including telephone interactions — making screening possible in any patient encounter.

The Framingham Heart Study, analyzing over 4,000 voice recordings paired with MRI-derived brain data, found that vocal markers including jitter, articulation rate, and lexical diversity are significantly associated with structural changes in memory-related brain regions.

A January 2026 clinical white paper demonstrates that machine learning models trained on spontaneous speech can serve as an effective first step in identifying individuals at risk for depression and anxiety — enabling earlier intervention at scale.

Peer-reviewed research validates speech-based depression severity detection — enabling nuanced assessment beyond binary present/absent screening.

Clinical research demonstrates reliable audio-based detection of both anxiety and depression through vocal biomarker analysis — validating voice as a dual-condition screening modality.

Research confirms that anxiety and depression are detectable from standard telephone conversations — without specialized equipment, clinical settings, or patient prompting.

Research demonstrates that a single conversational question contains sufficient vocal data to estimate anxiety levels, sleep quality, and mood states through computational voice analysis.

A study of 340 individuals confirms that voice is a reliable indicator of stress — with vocal analysis outperforming self-reported stress measures in clinical accuracy.

Research on voice technology for health monitoring in older adults validates fatigue detection through speech analysis — with direct applications to post-acute and long-term care settings.

Peer-reviewed research demonstrates that fatigue can be extracted as a measurable voice feature — enabling objective clinical assessment without patient self-reporting.

NIH-funded research published in Frontiers in Digital Health — convening experts from MIT, Mayo Clinic, Vanderbilt University Medical Center, and King's College London — confirms voice AI has reached translational readiness for clinical implementation, positioning it as a scalable, inclusive tool for next-generation healthcare.

A systematic scoping review from the University of Málaga, published in Biology (MDPI), confirms that voice production consistently engages the autonomic nervous system — with vocal markers providing measurable signals of stress, cognitive load, emotional state, and subclinical clinical conditions detectable before symptoms appear.

Applied research demonstrates voice biomarker technology reliably identifies stress and vulnerability indicators in conversational settings — with direct applications to clinical care environments.